PHYTOZOL Trademark

Trademark Overview

On Tuesday, November 28, 2017, a trademark application was filed for PHYTOZOL with the United States Patent and Trademark Office. The USPTO has given the PHYTOZOL trademark a serial number of 87699478. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, March 10, 2025. This trademark is owned by NuRemedy Pharma LLC. The PHYTOZOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations or formulations for transdermal delivery of treatments
phytozol

General Information

Serial Number87699478
Word MarkPHYTOZOL
Filing DateTuesday, November 28, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 10, 2025
Registration Number5608465
Registration DateTuesday, November 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations or formulations for transdermal delivery of treatments

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 7, 2017
Primary Code005
First Use Anywhere DateFriday, June 1, 2018
First Use In Commerce DateFriday, June 1, 2018

Trademark Owner History

Party NameNexzol Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
Party NameNexzol Pharma, Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92673
Party NameNuRemedy Pharma LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89144
Party NameNuRemedy Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89144

Trademark Events

Event DateEvent Description
Monday, March 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 1, 2017NEW APPLICATION ENTERED
Thursday, December 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 12, 2018ASSIGNED TO EXAMINER
Monday, March 12, 2018EXAMINERS AMENDMENT E-MAILED
Monday, March 12, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, March 12, 2018EXAMINER'S AMENDMENT ENTERED
Monday, March 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 18, 2018ASSIGNED TO LIE
Wednesday, April 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 23, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, April 24, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 23, 2018USE AMENDMENT FILED
Wednesday, September 19, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 19, 2018STATEMENT OF USE PROCESSING COMPLETE
Saturday, September 22, 2018SU - NON-FINAL ACTION - WRITTEN
Saturday, September 22, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 22, 2018NON-FINAL ACTION E-MAILED
Monday, October 8, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 9, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 7, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 10, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 11, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 13, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, November 7, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, March 10, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 10, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, March 10, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, November 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

phytozol delivery treatments transdermal formulations preparations pharmaceutical